THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors(1), and in particular Article 14 thereof,
Having regard to Council Regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Union and third countries in drug precursors(2), and in particular Article 6(3), the third subparagraph of Article 9(2) and Article 28 thereof,
Whereas:
(1) Commission Regulation (EC) No 1277/2005(3) lays down provisions for the implementation of Regulation (EC) No 273/2004 and Regulation (EC) No 111/2005 in the field of drug precursors. Both Regulation (EC) No 273/2004 and Regulation (EC) No 111/2005 have been amended after the adoption of Regulation (EC) No 1277/2005 so as to include empowerments to adopt delegated and implementing acts pursuant to Articles 290 and 291 of the Treaty. Therefore, new rules should be adopted in accordance with the new empowerments.
(2) Although Regulation (EC) No 273/2004 deals with domestic trade and Regulation (EC) No 111/2005 deals with international trade, many of the provisions are common to both Regulations. In order to ensure coherence, it is justified to adopt a single implementing act covering both Regulations.
(3) In order to ensure legal certainty and a coherent enforcement of the provisions of this Regulation, it is necessary to give a definition of ‘business premises’.
(4) The existing provisions regarding the procedural rules for granting licences, the procedure and format for providing information required to monitor trade, and the format and handling of import and export authorisations have proven to be effective and should therefore, in essence on substance, continue to apply by virtue of this Regulation.
(5) The procedural rules for granting registration to operators and users, as defined in Regulation (EC) No 273/2004 and Regulation (EC) No 111/2005, should reflect those for granting licences.
(6) In order to ensure data quality and coherence, and avoid duplication, in the information fed into the European database on drug precursors, each Member State should establish one single contact point transmitting the information to the database. Information should be transmitted without undue delay. Information on a licence or a registration should include the elements necessary for identifying the operator or user holding the licence or registration, as well as the substance(s) covered. Access to the information should be restricted to the minimum necessary for the public authorities' performance of their duties.
(7) Transitional rules should allow the use of paper forms issued before the entry into force of this Regulation in compliance with previous rules until the stocks of such paper forms have been exhausted.
(8) The measures provided for in this Regulation are in accordance with the opinion of the Drug Precursors Committee,
HAS ADOPTED THIS REGULATION:
This Regulation lays down uniform procedural rules for the implementation of Regulation (EC) No 273/2004 and of Regulation (EC) No 111/2005 as regards the licensing and registration of operators and users and their listing in the European database on drug precursors, the provision by operators of information required to monitor trade and authorisation of exports and imports in the field of drug precursors.
For the purposes of this Regulation, ‘business premises’ shall mean building(s) together with the land occupied by an operator at each single location.
1.An operator or user shall submit to the competent authority an application to obtain a licence referred to in Article 3(2) of Regulation (EC) No 273/2004 or Article 6(1) of Regulation (EC) No 111/2005, electronically or in writing as prescribed by the Member State concerned.
An application shall be deemed to be complete when it contains all the information listed in Article 3(2)(b) of Commission Delegated Regulation (EU) 2015/1011(4).
2.When assessing an application to obtain a licence, the competent authority may also take into consideration the results of any previous assessments or audits carried out on the applying operator holding the status of [F1Authorised Economic Operator for customs simplification (AEOC), to the extent they are relevant for the examination of the conditions for granting a licence.]
By derogation from Article 3(1) of this Regulation, the competent authority may authorise operators holding the status of [F2AEOC] not to submit all the information listed in Article 3(2)(b) of Delegated Regulation (EU) 2015/1011 when they are submitting an application.
3.The competent authority shall first assess the completeness of an application.
Where an application is not deemed to be complete, the competent authority shall indicate so to the applicant and invite that applicant to provide any missing or relevant additional information.
Where an application is deemed to be complete, the competent authority shall confirm the receipt of a complete application to the applicant.
4.The competent authority shall take a decision to grant or not to grant a licence within 60 working days from the date of receipt of a complete application in the case of a new licence, and within 30 working days in the case of a renewal of a licence.
5.Any decision not to grant a licence shall be reasoned and notified to the applicant electronically or in writing.
6.The licence may cover the operations referred to in Regulation (EC) No 273/2004 and Regulation (EC) No 111/2005.
Textual Amendments
F1Words in Art. 3(2) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(2); 2020 c. 1, Sch. 5 para. 1(1)
F2Word in Art. 3(2) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(3); 2020 c. 1, Sch. 5 para. 1(1)
The competent authority may grant a licence:
to cover all scheduled substances and all operations per business premises; or
to cover all scheduled substances and all operations per Member State.
A licence referred to in Article 3(2) of Regulation (EC) No 273/2004 or Article 6(1) of Regulation (EC) No 111/2005 shall be issued in the format set out in Annex I to this Regulation.
Where, after a licence has been granted, information provided in the application for that licence, other than information referred to in Article 3(9) of Delegated Regulation (EU) 2015/1011, has changed, the licence holder shall inform the competent authority electronically or in writing within 10 working days following the change.
Where, after the change, the conditions referred to in Article 3 of Delegated Regulation (EU) 2015/1011 continue to be fulfilled, and the information to be changed is contained in the licence, the competent authority shall amend the licence accordingly.
1.Where the validity of a licence has expired, or where a license has been revoked, the licence holder shall return a licence which is no longer valid to the competent authority within 10 working days following the date of expiry of validity or the date of revocation.
2.Where a competent authority decides to suspend or revoke a licence, the decision shall be submitted to the licence holder electronically or in writing and shall specify the grounds that justify the suspension or revocation.
Articles 3 to 7 of this Regulation shall not apply to special licences referred to in Article 3(2) of Regulation (EC) No 273/2004.
1.Articles 3, 4, 6 and 7 shall apply to the procedure for registration pursuant to Article 3(6) of Regulation (EC) No 273/2004 or Article 7(1) of Regulation (EC) No 111/2005.
2.Registration pursuant to Article 3(6) of Regulation (EC) No 273/2004 or Article 7(1) of Regulation (EC) No 111/2005 shall be granted in the format set out in Annex II.
3.By way of derogation from paragraph 2, the competent authority may grant registration on a form printed before the date of entry into force of this Regulation and complying with national rules in place before the date of entry into force of this Regulation until the stocks are exhausted.
4.Paragraphs 1, 2 and 3 shall not apply to special registrations referred to in Article 3(6) of Regulation (EC) No 273/2004.
1.Operators shall provide the information referred to in Article 8(2) of Regulation (EC) No 273/2004 electronically or in writing, [F3as specified by the Secretary of State], before 15 February of each calendar year for scheduled substances of Categories 1 and 2 of Annex I to that Regulation.
2.Operators shall provide the information referred to in Article 9(2) of Regulation (EC) No 111/2005 electronically or in writing, [F4as specified by the Secretary of State], before 15 February of each calendar year.
3.An operator shall submit the annual reports referred to in paragraphs 1 and 2 even where no transactions have taken place in a given year.
Textual Amendments
F3Words in Art. 10(1) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(4); 2020 c. 1, Sch. 5 para. 1(1)
F4Words in Art. 10(2) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(4); 2020 c. 1, Sch. 5 para. 1(1)
1.The export and import authorisations referred to in Article 28 of Regulation (EC) No 111/2005 shall have the format set out in Annex III or IV to this Regulation, respectively.
By way of derogation from the first subparagraph, the box relating to the authorisation number may have a different format in cases where the export or import authorisation is granted by electronic means.
2.An export authorisation shall be established in four copies numbered 1 to 4. Copy No 1 shall be kept by the authority issuing the authorisation. Copies No 2 and No 3 shall accompany the scheduled substance and be presented to the customs office where the customs export declaration is made, and subsequently to the competent authority at the point of exit from the [F5United Kingdom]. The competent authority at the point of exit shall return Copy No 2 to the issuing authority. Copy No 3 shall accompany the scheduled substances to the competent authority of the importing country. Copy No 4 shall be kept by the exporter.
3.An import authorisation shall be established in four copies numbered 1 to 4. Copy No 1 shall be kept by the authority issuing the authorisation. Copy No 2 shall be sent to the competent authority of the exporting country by the issuing authority. Copy No 3 shall accompany the scheduled substance from the point of entry into the [F6United Kingdom] to the business premises of the importer, who shall send this copy to the issuing authority. Copy No 4 shall be kept by the importer.
4.One single export or import authorisation shall not cover more than two scheduled substances.
5.F7... Unless [F8an authorisation] is granted by electronic means, it shall have A4 format and a printed guilloche pattern background making any falsification by mechanical or chemical means apparent to the eye.
6.[F9The Secretary of State] may print the authorisation forms F10... or have them printed by printers approved by [F11the Secretary of State]. In the latter case, each authorisation form must include a reference of such approval and bear the name and address of the printer or a mark by which the printer can be identified.
F127.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8.Export authorisations granted by simplified procedure shall be established using copies No 1, 2 and 4 of the form set out in Annex III. Copy No 1 shall be kept by the authority issuing the authorisation. Copy No 2 and Copy No 4 shall remain with the exporter. The exporter shall indicate details of each export operation on the back side of Copy No 2, in particular the quantity of the scheduled substance of each export operation and the remaining quantity. Copy No 2 shall be presented to the customs office when the customs declaration is made. That customs office shall confirm the details and return Copy No 2 to the exporter.
9.The operator shall enter the authorisation number and the words ‘simplified export authorisation procedure’ on the customs declaration for each export operation. F13...
10.The exporter shall return Copy No 2 to the issuing authority at the latest 10 working days following the expiry of the period of validity of the export authorisation granted by simplified procedure.
Textual Amendments
F5Words in Art. 11(2) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(5)(a); 2020 c. 1, Sch. 5 para. 1(1)
F6Words in Art. 11(3) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(5)(b); 2020 c. 1, Sch. 5 para. 1(1)
F7Words in Art. 11(5) omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(5)(c)(i); 2020 c. 1, Sch. 5 para. 1(1)
F8Words in Art. 11(5) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(5)(c)(ii); 2020 c. 1, Sch. 5 para. 1(1)
F9Words in Art. 11(6) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(5)(d)(i); 2020 c. 1, Sch. 5 para. 1(1)
F10Word in Art. 11(6) omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(5)(d)(ii); 2020 c. 1, Sch. 5 para. 1(1)
F11Words in Art. 11(6) substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(5)(d)(iii); 2020 c. 1, Sch. 5 para. 1(1)
F12Art. 11(7) omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(5)(e); 2020 c. 1, Sch. 5 para. 1(1)
F13Words in Art. 11(9) omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(5)(f); 2020 c. 1, Sch. 5 para. 1(1)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F14Art. 12 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(6); 2020 c. 1, Sch. 5 para. 1(1)
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.
F15...
Done at Brussels, 25 June 2015.
For the Commission
The President
Jean-Claude Juncker
Textual Amendments
F15Words in Signature omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(7); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F16Annex 1 Form: the European Union flag is omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)
F17Annex 1 Form heading “ United Kingdom ” substituted for “European Union” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)
The layout of the model is not binding.
The order numbers and the text of the model are binding. The completion of the boxes marked in bold is mandatory.
Details of the boxes:
Box 1 (Licence holder): The name of the responsible officer may be added.
Box 3 (validity/end): Specify the term of validity or whether licence holders are obliged to demonstrate at intervals not exceeding three years that the conditions under which the licence was granted are still fulfilled.
Box 4 (scheduled substances): Name of the scheduled substance as stated in the Annex, or, in the case of a mixture or a natural product, its name and the name of any scheduled substance, as stated in the Annex, contained in the mixture or in the natural product. Indicate salts, where appropriate.
Box 4 (CN code): In addition to the CN code, the CAS number may be added.
Box 4 (operation): Specify export, import and/or intermediary activities. In the case of import, specify whether storage, working, processing, use, usual forms of handling and/or release for free circulation, where appropriate. For operations covered by Regulation (EC) No 273/2004, specify: storage, production, manufacture, processing, trade, distribution and/or brokering.
Box 4 (business premises): In the case of intermediary activities referred to in Article 2 of Regulation (EC) No 111/2005, the business premises need not be specified.
F18...
Personal data protection
F19...
F20...
The purpose of the processing of personal data is the monitoring of trade in drug precursors within the [F21United Kingdom] in accordance to Regulation (EC) No 273/2004 as amended by Regulation (EU) No 1258/2013, and between the [F21United Kingdom] and third countries in accordance with Regulation (EC) No 111/2005, as amended by Regulation (EU) No 1259/2013.
The controller with respect to the processing of the data is the F22... competent authority where the present document has been submitted. F22...
F22...
In accordance with Article 17 of Regulation (EC) No 111/2005 laying down rules for the monitoring of trade in drug precursors between the [F23United Kingdom] and third countries, without prejudice to applicable provisions on data protection in the [F23United Kingdom] and for the purpose of controlling and monitoring certain substances frequently used for the illicit manufacture of narcotic drugs or psychotropic substances, [F23competent authorities] may share personal data and information contained in the present document with the relevant authorities in third countries.
The data subject has a right of access to the personal data relating to him or her that will be processed and, where appropriate, the right to rectify erase or block personal data in accordance with Regulation (EC) No 45/2001 [F24or the Data Protection Act 2018].
All requests for the exercise of the right of access, rectification, erasure or blocking shall be submitted to and processed by the competent authorities where the present document was submitted.
The legal basis for processing the personal data is Article 33 of Regulation (EC) No 111/2005 and Article 13b of Regulation (EC) No 273/2004.
Personal data contained in the present document shall not be retained longer than necessary for the purposes for which it was collected.
Complaints, in case of conflict, can be addressed to the relevant national data protection authority. F25...
F26...
Textual Amendments
F18Words in Annex 1 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(b)(i); 2020 c. 1, Sch. 5 para. 1(1)
F19Words in Annex 1 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(b)(ii)(aa); 2020 c. 1, Sch. 5 para. 1(1)
F20Words in Annex 1 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(b)(ii)(bb); 2020 c. 1, Sch. 5 para. 1(1)
F21Words in Annex 1 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(b)(ii)(cc); 2020 c. 1, Sch. 5 para. 1(1)
F22Words in Annex 1 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(b)(ii)(dd); 2020 c. 1, Sch. 5 para. 1(1)
F23Words in Annex 1 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(b)(ii)(ee); 2020 c. 1, Sch. 5 para. 1(1)
F24Words in Annex 1 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(b)(ii)(ff); 2020 c. 1, Sch. 5 para. 1(1)
F25Words in Annex 1 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(b)(ii)(gg); 2020 c. 1, Sch. 5 para. 1(1)
F26Words in Annex 1 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(8)(b)(ii)(hh); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F27Annex 2 Form: the European Union flag is omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)
F28Annex 2 Form heading “European Union” omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)
The layout of the model is not binding.
The order numbers and the text of the model are binding. The completion of the boxes marked in bold is mandatory.
Details of the boxes:
Box 1 (Registration holder): The name of the responsible officer may be added.
Box 3 (validity/end): Specify the beginning and, where relevant, the end of validity.
Box 4 (scheduled substances): Name of the scheduled substance as stated in the Annex, or, in the case of a mixture or a natural product, its name and the name of any scheduled substance, as stated in the Annex, contained in the mixture or in the natural product. Indicate salts, where appropriate.
Box 4 (CN code): In addition to the CN code, the CAS number may be added.
Box 4 (operation): Specify export, import and/or intermediary activities. In the case of import, specify whether storage, working, processing, use, usual forms of handling and/or release for free circulation, where appropriate. For operations covered by Regulation (EC) No 273/2004, specify: storage, production, manufacture, processing, trade, distribution and/or brokering.
Box 4 (business premises): In the case of intermediary activities referred to in Article 2 of Regulation (EC) No 111/2005, the business premises need not be specified.
F29...
Personal data protection
F30...
F31...
The purpose of the processing of personal data is the monitoring of trade in drug precursors within the [F32United Kingdom] in accordance to Regulation (EC) No 273/2004 as amended by Regulation (EU) No 1258/2013, and between the [F32United Kingdom] and third countries in accordance with Regulation (EC) No 111/2005, as amended by Regulation (EU) No 1259/2013.
The controller with respect to the processing of the data is the F33... competent authority where the present document has been submitted. F33...
F33...
In accordance with Article 17 of Regulation (EC) No 111/2005 laying down rules for the monitoring of trade in drug precursors between the [F34United Kingdom] and third countries, without prejudice to applicable provisions on data protection in the [F34United Kingdom] and for the purpose of controlling and monitoring certain substances frequently used for the illicit manufacture of narcotic drugs or psychotropic substances, [F34competent authorities] may share personal data and information contained in the present document with the relevant authorities in third countries.
The data subject has a right of access to the personal data relating to him or her that will be processed and, where appropriate, the right to rectify erase or block personal data in accordance with Regulation (EC) No 45/2001 [F35or the Data Protection Act 2018].
All requests for the exercise of the right of access, rectification, erasure or blocking shall be submitted to and processed by the competent authorities where the present document was submitted.
The legal basis for processing the personal data is Article 33 of Regulation (EC) No 111/2005 and Article 13b of Regulation (EC) No 273/2004.
Personal data contained in the present document shall not be retained longer than necessary for the purposes for which it was collected.
Complaints, in case of conflict, can be addressed to the relevant national data protection authority. F36...
F37...
Textual Amendments
F29Words in Annex 2 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(i); 2020 c. 1, Sch. 5 para. 1(1)
F30Words in Annex 2 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(ii)(aa); 2020 c. 1, Sch. 5 para. 1(1)
F31Words in Annex 2 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(ii)(bb); 2020 c. 1, Sch. 5 para. 1(1)
F32Words in Annex 2 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(ii)(cc); 2020 c. 1, Sch. 5 para. 1(1)
F33Words in Annex 2 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(ii)(dd); 2020 c. 1, Sch. 5 para. 1(1)
F34Words in Annex 2 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(ii)(ee); 2020 c. 1, Sch. 5 para. 1(1)
F35Words in Annex 2 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(ii)(ff); 2020 c. 1, Sch. 5 para. 1(1)
F36Words in Annex 2 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(ii)(gg); 2020 c. 1, Sch. 5 para. 1(1)
F37Words in Annex 2 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(9)(b)(ii)(hh); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F38Annex 3 Form heading “UNITED KINGDOM ” substituted for “EUROPEAN UNION” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)
F39Annex 3 Form box 22 “UK” substituted for “EU” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(a)(ii)(aa); 2020 c. 1, Sch. 5 para. 1(1)
F40Annex 3 Form box 22 “United Kingdom” substituted for “customs territory of the Union” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(a)(ii)(bb); 2020 c. 1, Sch. 5 para. 1(1)
I.
Textual Amendments
F41Words in Annex 3 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(i); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F42Words in Annex 3 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(ii); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F43Words in Annex 3 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(iii); 2020 c. 1, Sch. 5 para. 1(1)
Indicate in block letters the name of the applicant or, where appropriate, of the authorised representative who signs this application.
The signature by the applicant or authorised representative F44... indicates that the person concerned is declaring that all the particulars provided on the application are correctly and fully stated. Without prejudice to the possible application of penal provisions, this declaration is equivalent to the engagement of responsibility, under the provisions in force F44..., in respect of the following:
the accuracy of the information given in the declaration;
the authenticity of any documents attached;
the observance of all the obligations inherent in the export of scheduled substances listed in the Annex to Regulation (EC) No 111/2005.
Whenever the authorisation is issued by means of a computerised procedure, that authorisation may not contain the signature of the applicant in this box, if the application as such contains such signature.
Textual Amendments
F44Words in Annex 3 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(iv); 2020 c. 1, Sch. 5 para. 1(1)
(Simplified export authorisation procedure)U.K.
Column 24: Indicate the quantity available in part 1 and the quantity of the partial export quantity in part 2. For Category 4, enter the total net weight quantity of the scheduled substance contained in the consignment of medicinal products.
Column 25: Indicate the partial export quantity in words.
Box 26: Reference number and the date of the customs declaration.
F45...U.K.
Textual Amendments
F45Words in Annex 3 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(v)(aa); 2020 c. 1, Sch. 5 para. 1(1)
F46...
Textual Amendments
F46Words in Annex 3 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(v)(bb); 2020 c. 1, Sch. 5 para. 1(1)
The purpose of the processing of personal data is the monitoring of trade in drug precursors within the [F47United Kingdom] in accordance to Regulation (EC) No 273/2004 as amended by Regulation (EU) No 1258/2013, and between the [F47United Kingdom] and third countries in accordance with Regulation (EC) No 111/2005, as amended by Regulation (EU) No 1259/2013.
Textual Amendments
F47Words in Annex 3 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(v)(cc); 2020 c. 1, Sch. 5 para. 1(1)
The controller with respect to the processing of the data is the F48... competent authority where the present document has been submitted. F48...
Textual Amendments
F48Words in Annex 3 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(v)(dd); 2020 c. 1, Sch. 5 para. 1(1)
F48...
In accordance with Article 17 of Regulation (EC) No 111/2005 laying down rules for the monitoring of trade in drug precursors between the [F49United Kingdom] and third countries, without prejudice to applicable provisions on data protection in the [F49United Kingdom] and for the purpose of controlling and monitoring certain substances frequently used for the illicit manufacture of narcotic drugs or psychotropic substances, [F49competent authorities] may share personal data and information contained in the present document with the relevant authorities in third countries.
Textual Amendments
F49Words in Annex 3 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(v)(ee); 2020 c. 1, Sch. 5 para. 1(1)
The data subject has a right of access to the personal data relating to him or her that will be processed and, where appropriate, the right to rectify erase or block personal data in accordance with Regulation (EC) No 45/2001 [F50or the Data Protection Act 2018].
Textual Amendments
F50Words in Annex 3 notes substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(v)(ff); 2020 c. 1, Sch. 5 para. 1(1)
All requests for the exercise of the right of access, rectification, erasure or blocking shall be submitted to and processed by the competent authorities where the present document was submitted.
The legal basis for processing the personal data is Article 33 of Regulation (EC) No 111/2005 and Article 13b of Regulation (EC) No 273/2004.
Personal data contained in the present document shall not be retained longer than necessary for the purposes for which it was collected.
Complaints, in case of conflict, can be addressed to the relevant national data protection authority. F51...
Textual Amendments
F51Words in Annex 3 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(v)(gg); 2020 c. 1, Sch. 5 para. 1(1)
F52...
Textual Amendments
F52Words in Annex 3 notes omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(10)(b)(v)(hh); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F53Annex 4 Forms heading “UNITED KINGDOM” substituted for “EUROPEAN UNION” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)
F54Annex 4 Forms Box 9 “United Kingdom” substituted for “customs territory of the Union” (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F55Words in Annex 4 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(i); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F56Words in Annex 4 substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(ii); 2020 c. 1, Sch. 5 para. 1(1)
Textual Amendments
F57Words in Annex 4 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(iii); 2020 c. 1, Sch. 5 para. 1(1)
Box 13 a, 13b: for Category 4, enter the total net weight of the scheduled substance contained in the consignment of medicinal products.
Indicate in block letters the name of the applicant or, where appropriate, of his authorised representative who signs this application.
The signature by the applicant or his authorised representativeF58... indicates that the person concerned is declaring that all the particulars provided on the application are correctly and fully stated. Without prejudice to the possible application of penal provisions, this declaration is equivalent to the engagement of responsibility, under the provisions in force F58..., in respect of the following:
the accuracy of the information;
the authenticity of any documents attached;
the observance of all other obligations.
Whenever the authorisation is issued by means of a computerised procedure, that authorisation may not contain the signature of the applicant in this box, if the application as such contains such signature.
Textual Amendments
F58Words in Annex 4 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(iv); 2020 c. 1, Sch. 5 para. 1(1)
F59...
Textual Amendments
F59Words in Annex 4 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(v)(aa); 2020 c. 1, Sch. 5 para. 1(1)
F60...
Textual Amendments
F60Words in Annex 4 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(v)(bb); 2020 c. 1, Sch. 5 para. 1(1)
The purpose of the processing of personal data is the monitoring of trade in drug precursors within the [F61United Kingdom] in accordance to Regulation (EC) No 273/2004 as amended by Regulation (EU) No 1258/2013, and between the [F61United Kingdom] and third countries in accordance with Regulation (EC) No 111/2005, as amended by Regulation (EU) No 1259/2013.
Textual Amendments
F61Words in Annex 4 substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(v)(cc); 2020 c. 1, Sch. 5 para. 1(1)
The controller with respect to the processing of the data is the F62... competent authority where the present document has been submitted. F62...
Textual Amendments
F62Words in Annex 4 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(v)(dd); 2020 c. 1, Sch. 5 para. 1(1)
In accordance with Article 17 of Regulation (EC) No 111/2005 laying down rules for the monitoring of trade in drug precursors between the [F63United Kingdom] and third countries, without prejudice to applicable provisions on data protection in the [F63United Kingdom] and for the purpose of controlling and monitoring certain substances frequently used for the illicit manufacture of narcotic drugs or psychotropic substances, [F63competent authorities] may share personal data and information contained in the present document with the relevant authorities in third countries.
Textual Amendments
F63Words in Annex 4 substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(v)(ee); 2020 c. 1, Sch. 5 para. 1(1)
The data subject has a right of access to the personal data relating to him or her that will be processed and, where appropriate, the right to rectify erase or block personal data in accordance with Regulation (EC) No 45/2001 [F64or the Data Protection Act 2018].
Textual Amendments
F64Words in Annex 4 substituted (31.12.2020) by The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(v)(ff); 2020 c. 1, Sch. 5 para. 1(1)
All requests for the exercise of the right of access, rectification, erasure or blocking shall be submitted to and processed by the competent authorities where the present document was submitted.
The legal basis for processing the personal data is Article 33 of Regulation (EC) No 111/2005 and Article 13b of Regulation (EC) No 273/2004.
Personal data contained in the present document shall not be retained longer than necessary for the purposes for which it was collected.
Complaints, in case of conflict, can be addressed to the relevant national data protection authority. F65...
Textual Amendments
F65Words in Annex 4 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(v)(gg); 2020 c. 1, Sch. 5 para. 1(1)
F66...
Textual Amendments
F66Words in Annex 4 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 16(11)(b)(v)(hh); 2020 c. 1, Sch. 5 para. 1(1)
Commission Regulation (EC) No 1277/2005 of 27 July 2005 laying down implementing rules for Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and for Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors (OJ L 202, 3.8.2005, p. 7).
Commission Delegated Regulation (EU) 2015/1011 of 24 April 2015 supplementing Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third countries in drug precursors, and repealing Commission Regulation (EC) No 1277/2005 (see page 12 of this Official Journal).